These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22394478)

  • 1. Drug target validation of the trypanothione pathway enzymes through metabolic modelling.
    Olin-Sandoval V; González-Chávez Z; Berzunza-Cruz M; Martínez I; Jasso-Chávez R; Becker I; Espinoza B; Moreno-Sánchez R; Saavedra E
    FEBS J; 2012 May; 279(10):1811-33. PubMed ID: 22394478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity.
    González-Chávez Z; Vázquez C; Mejia-Tlachi M; Márquez-Dueñas C; Manning-Cela R; Encalada R; Rodríguez-Enríquez S; Michels PAM; Moreno-Sánchez R; Saavedra E
    Redox Biol; 2019 Sep; 26():101231. PubMed ID: 31203195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buthionine sulfoximine is a multitarget inhibitor of trypanothione synthesis in Trypanosoma cruzi.
    Vázquez C; Mejia-Tlachi M; González-Chávez Z; Silva A; Rodríguez-Zavala JS; Moreno-Sánchez R; Saavedra E
    FEBS Lett; 2017 Dec; 591(23):3881-3894. PubMed ID: 29127710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Trypanosoma brucei trypanothione synthetase as drug target.
    Comini MA; Guerrero SA; Haile S; Menge U; Lünsdorf H; Flohé L
    Free Radic Biol Med; 2004 May; 36(10):1289-302. PubMed ID: 15110394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanothione biosynthesis in Leishmania major.
    Oza SL; Shaw MP; Wyllie S; Fairlamb AH
    Mol Biochem Parasitol; 2005 Jan; 139(1):107-16. PubMed ID: 15610825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting trypanothione metabolism in trypanosomatid human parasites.
    Olin-Sandoval V; Moreno-Sánchez R; Saavedra E
    Curr Drug Targets; 2010 Dec; 11(12):1614-30. PubMed ID: 20735352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cynaropicrin targets the trypanothione redox system in Trypanosoma brucei.
    Zimmermann S; Oufir M; Leroux A; Krauth-Siegel RL; Becker K; Kaiser M; Brun R; Hamburger M; Adams M
    Bioorg Med Chem; 2013 Nov; 21(22):7202-9. PubMed ID: 24080104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design.
    Aguirre G; Cabrera E; Cerecetto H; Di Maio R; González M; Seoane G; Duffaut A; Denicola A; Gil MJ; Martínez-Merino V
    Eur J Med Chem; 2004 May; 39(5):421-31. PubMed ID: 15110968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting the essentiality of the bifunctional trypanothione synthetase-amidase in Trypanosoma brucei using chemical and genetic methods.
    Wyllie S; Oza SL; Patterson S; Spinks D; Thompson S; Fairlamb AH
    Mol Microbiol; 2009 Nov; 74(3):529-40. PubMed ID: 19558432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key proteins in the polyamine-trypanothione pathway as drug targets against Trypanosoma cruzi.
    Maya JD; Salas CO; Aguilera-Venegas B; Diaz MV; López-Muñoz R
    Curr Med Chem; 2014; 21(15):1757-71. PubMed ID: 24251576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Control Analysis for Drug Target Prioritization in Trypanosomatids.
    González-Chávez Z; Vázquez C; Moreno-Sánchez R; Saavedra E
    Methods Mol Biol; 2020; 2116():689-718. PubMed ID: 32221950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs.
    Colotti G; Baiocco P; Fiorillo A; Boffi A; Poser E; Chiaro FD; Ilari A
    Future Med Chem; 2013 Oct; 5(15):1861-75. PubMed ID: 24144416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of substrate analogue inhibitors of trypanothione reductase.
    Duyzend MH; Clark CT; Simmons SL; Johnson WB; Larson AM; Leconte AM; Wills AW; Ginder-Vogel M; Wilhelm AK; Czechowicz JA; Alberg DG
    J Enzyme Inhib Med Chem; 2012 Dec; 27(6):784-94. PubMed ID: 22085139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic analysis of trypanothione synthetase knockdown in the African trypanosome.
    Ariyanayagam MR; Oza SL; Guther ML; Fairlamb AH
    Biochem J; 2005 Oct; 391(Pt 2):425-32. PubMed ID: 16008527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanothione synthetase confers growth, survival advantage and resistance to anti-protozoal drugs in Trypanosoma cruzi.
    Mesías AC; Sasoni N; Arias DG; Pérez Brandán C; Orban OCF; Kunick C; Robello C; Comini MA; Garg NJ; Zago MP
    Free Radic Biol Med; 2019 Jan; 130():23-34. PubMed ID: 30359758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The trypanothione system and its implications in the therapy of trypanosomatid diseases.
    Flohé L
    Int J Med Microbiol; 2012 Oct; 302(4-5):216-20. PubMed ID: 22889611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ellman's-reagent-mediated regeneration of trypanothione in situ: substrate-economical microplate and time-dependent inhibition assays for trypanothione reductase.
    Hamilton CJ; Saravanamuthu A; Eggleston IM; Fairlamb AH
    Biochem J; 2003 Feb; 369(Pt 3):529-37. PubMed ID: 12416994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting the catalytic mechanism of Trypanosoma brucei trypanothione synthetase by kinetic analysis and computational modeling.
    Leroux AE; Haanstra JR; Bakker BM; Krauth-Siegel RL
    J Biol Chem; 2013 Aug; 288(33):23751-64. PubMed ID: 23814051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single enzyme catalyses formation of Trypanothione from glutathione and spermidine in Trypanosoma cruzi.
    Oza SL; Tetaud E; Ariyanayagam MR; Warnon SS; Fairlamb AH
    J Biol Chem; 2002 Sep; 277(39):35853-61. PubMed ID: 12121990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanothione as a target in the design of antitrypanosomal and antileishmanial agents.
    Augustyns K; Amssoms K; Yamani A; Rajan PK; Haemers A
    Curr Pharm Des; 2001 Aug; 7(12):1117-41. PubMed ID: 11472257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.